跳至主要内容
临床试验/CTRI/2023/03/051035
CTRI/2023/03/051035已完成4 期

A Cross over, Double blinded, Interventional study to evaluate the skin sensitivity, safety and tolerability of two types of Amrutanjan Pain Balm in healthy subjects

Amrutanjan Health Care Limited, Tamil Nadu, India.0 个研究点目标入组 12 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of either sex aged above 18 years.
  • 2.Patients who are able to understand written and/or verbal instructions and are ready to comply with all study requirements with a willingness to participate and give written informed consent voluntarily.

排除标准

  • 1.Past history of allergy, asthma and atopy.
  • 2.Known allergy to compounds of investigational product.
  • 3.Participation in an investigational drug trial in the 30 days prior to the screening visit.
  • 4.Patients of vulnerable group (children, lactating mother, elderly >80 years, handicapped, seriously ill, mentally challenged).
  • 5.Subjects with known history of Sinusitis, Migraine.

研究者

发起方
Amrutanjan Health Care Limited, Tamil Nadu, India.

相似试验